IRIS
SPINA, Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.302
NA - Nord America 15.031
AS - Asia 9.041
SA - Sud America 3.187
AF - Africa 259
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 13
Totale 44.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.728
RU - Federazione Russa 8.290
SG - Singapore 3.892
BR - Brasile 2.780
CN - Cina 2.452
IE - Irlanda 2.099
SE - Svezia 1.701
IT - Italia 1.388
HK - Hong Kong 1.001
UA - Ucraina 909
DE - Germania 908
FR - Francia 538
VN - Vietnam 522
FI - Finlandia 456
GB - Regno Unito 389
IN - India 341
PL - Polonia 213
AR - Argentina 148
CA - Canada 136
BD - Bangladesh 123
MX - Messico 104
TR - Turchia 91
IQ - Iraq 87
NL - Olanda 84
ZA - Sudafrica 72
ID - Indonesia 66
EC - Ecuador 65
BE - Belgio 60
JP - Giappone 55
PK - Pakistan 52
ES - Italia 51
UZ - Uzbekistan 51
CO - Colombia 49
MA - Marocco 47
AT - Austria 42
CL - Cile 42
VE - Venezuela 42
EE - Estonia 32
PH - Filippine 28
AE - Emirati Arabi Uniti 26
DZ - Algeria 26
SA - Arabia Saudita 26
KE - Kenya 23
AZ - Azerbaigian 22
EG - Egitto 22
TN - Tunisia 22
UY - Uruguay 21
MY - Malesia 20
NP - Nepal 20
CI - Costa d'Avorio 19
JO - Giordania 19
KZ - Kazakistan 18
AU - Australia 17
LT - Lituania 17
OM - Oman 17
AL - Albania 16
JM - Giamaica 16
PY - Paraguay 16
CZ - Repubblica Ceca 14
PE - Perù 14
IL - Israele 13
BG - Bulgaria 12
CH - Svizzera 12
CR - Costa Rica 12
GR - Grecia 12
LB - Libano 11
IR - Iran 10
KG - Kirghizistan 9
RS - Serbia 9
TH - Thailandia 9
AM - Armenia 8
BO - Bolivia 8
DO - Repubblica Dominicana 8
PS - Palestinian Territory 8
RO - Romania 8
SN - Senegal 8
KR - Corea 7
LV - Lettonia 7
EU - Europa 6
GE - Georgia 6
HN - Honduras 6
PA - Panama 6
TW - Taiwan 6
ET - Etiopia 5
HR - Croazia 5
NI - Nicaragua 5
BN - Brunei Darussalam 4
KH - Cambogia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
HU - Ungheria 3
LK - Sri Lanka 3
MT - Malta 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
Totale 44.807
Salva come PNG Salva come JPEG
Città #
Moscow 2.644
Singapore 2.128
Dublin 2.086
Ashburn 2.043
Jacksonville 1.750
Dallas 1.706
Chandler 1.519
Hong Kong 997
Beijing 895
Nyköping 748
San Jose 523
Princeton 399
The Dalles 396
Cambridge 360
Dearborn 358
Lauterbourg 348
Los Angeles 314
Des Moines 286
Medford 246
Messina 234
Boardman 225
New York 211
São Paulo 210
Ann Arbor 194
Buffalo 194
Warsaw 194
Ho Chi Minh City 170
Council Bluffs 149
Hyderabad 136
Munich 136
Tianjin 126
Wilmington 124
Hanoi 106
Houston 99
Guangzhou 97
Redondo Beach 94
Lancaster 93
Milan 93
Rio de Janeiro 87
Santa Clara 83
Rome 78
Woodbridge 77
Jinan 75
Orem 74
Seattle 74
Frankfurt am Main 69
Belo Horizonte 68
Turku 68
Shenyang 65
Bremen 63
San Mateo 63
Brussels 57
Brasília 53
Nanjing 49
Curitiba 46
Pune 46
Tokyo 46
Montreal 45
Tashkent 44
Catania 41
Chennai 40
Baghdad 38
Hangzhou 37
Johannesburg 35
Hebei 34
London 34
Porto Alegre 34
Campinas 33
Denver 32
Haikou 32
Helsinki 32
Nuremberg 31
Zhengzhou 31
Mexico City 30
Shenzhen 30
Atlanta 29
Chicago 29
Brooklyn 28
Norwalk 27
San Francisco 27
Stockholm 27
Boston 26
Ningbo 26
Phoenix 26
Taizhou 26
Guarulhos 25
Haiphong 25
Mumbai 25
Recife 25
Shanghai 25
Vienna 25
Washington 25
Amsterdam 24
Dhaka 24
Manchester 23
Salvador 23
Baku 22
Changsha 22
Contagem 22
Guayaquil 22
Totale 25.133
Salva come PNG Salva come JPEG
Nome #
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 444
Cutis verticis gyrata primitiva o pachidermia verticis gyrata: contributo clinico-istologico 337
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 285
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 266
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 250
6-Mer Hyaluronan Oligosaccharides ModulateNeuroinflammation and a-Synuclein Expression inNeuron-Like SH-SY5Y Cells 235
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 226
Acute Cerebellar Ataxia Following Meningococcal Group C Conjugate Vaccination 221
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 217
Confronto Teofillina-Doxofillina nella risoluzione del broncospasmo 214
Aripiprazolo in bambini con ADHD in comorbidità con Disturbo da Tic 211
"Valproic acid-amitriptyline interaction in man 200
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 197
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 197
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 196
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 194
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 192
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 191
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 190
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 187
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 187
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. 187
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder 185
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 185
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 185
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 184
ECG parameters in children and adolescents treated with aripiprazole and risperidone 184
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 183
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity 182
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 182
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 181
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report 179
ABCB1 polymorphisms influence steady state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. 178
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 178
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 176
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients 175
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 173
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 172
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 170
Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescent. 170
Clinically Relevant Drug Interactions Between Statins and Antidepressants 169
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 168
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 168
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 167
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 166
A double-blind comparative study of bromperidol versus halperidol in schizophrenic patients 166
Aripiprazole enhances the antidepressat effect of fluoxetine in mice. 165
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications 164
A pharmacokinetic-pharmacodynamic method for predicting warfarin maintenance dose: preliminary results 164
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 164
Efficacia e tollerabilità della quetiapina vs. clozapina in pazienti anziani parkinsoniani con psicosi dopaminergica. 164
Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. 164
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 163
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 162
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 162
AN ENDOCRINOLOGIC STUDY OF PATIENTS WITH PRIMARY-CUTIS-VERTICIS GYRATA 161
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 161
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 161
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 160
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 159
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population 157
5-HT2A and 5-HT2C receptor polymorphisms and psychotic symptoms in Alzheimer's disease 157
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 157
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 155
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 154
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 154
Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database 154
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 152
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 150
Uso dell’Aripiprazolo in bambini con Multiple-complex Developmental Disorder (McDD). 150
Tossicità cardiovascolare degli antipsicotici atipici in età evolutiva 150
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 150
Early atypical injection-site reactions to COVID-19 vaccine: a case series 149
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 149
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with Attention Deficit Hyperactivity Disorder 149
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 148
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 148
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 147
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 147
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years 146
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 146
Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. 146
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 146
PARKINSONISMO ED INIBITORI SELETTIVI DEL REUPTAKE DELLA SEROTONINA 145
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 145
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 145
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 145
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 144
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. 144
ADJUNCTIVE FLUOXETINE IN THE TREATMENT OF NEGATIVE SYMPTOMS IN CHRONIC-SCHIZOPHRENIC PATIENTS 141
Impiego clinico del Risperidone in età evolutiva: variazioni farmacocinetiche e cliniche 140
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 140
Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. 139
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 139
Impiego del Risperidone nel disturbo autistico: valutazioni farmacocinetiche e cliniche 137
Effect of valproate on plasma concentrations of olanzapine in patients with psychotic disorders , July, 2009, MP 110.. 137
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 137
USE AND TOLERABILITY OF NEWER ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A CHART REVIEW IN A PAEDIATRIC SETTING. 136
Caratterizzazione delle reazioni avverse a farmaci segnalate da un reparto di Allergologia e Immunologia Clinica 135
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis 135
Totale 17.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021140 0 0 0 0 0 0 0 0 0 0 0 140
2021/20222.222 27 224 31 77 50 23 133 113 82 446 293 723
2022/20235.891 508 409 218 480 521 541 52 346 2.547 28 175 66
2023/20241.669 121 246 109 169 168 336 70 102 26 164 19 139
2024/20257.233 96 95 156 400 381 219 137 1.640 1.933 445 580 1.151
2025/202620.801 905 1.406 1.798 1.469 1.589 4.515 2.401 2.471 2.566 892 419 370
Totale 45.283